Absorbed dose microdistribution of 177Lu and 225Ac in a model of cancer associated fibroblasts

被引：0
|
作者：
Tranel, J. [1 ]
Palm, S. [2 ]
Graves, S. A. [3 ]
Feng, F. Y. [1 ]
Hope, T. A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Gothenburg, Gothenburg, Sweden
[3] Univ Iowa, Iowa City, IA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-625
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [31] Comparison of PSMA-TO-1 and PSMA-617 labelled with 68Ga, 177Lu and 225Ac: a first in-human translational study
    Meyer, C.
    Prasad, V.
    Stuparu, A.
    Glatting, G.
    Kletting, P.
    Miksch, J.
    Solbach, C.
    Lueckerath, K.
    Nyiranshuti, L.
    Zhu, S.
    Czernin, J.
    Dahlbom, M.
    Calais, J.
    Beer, A.
    Slavik, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S43 - S43
  • [32] Comparison Between Different Methods of Red Marrow Absorbed Dose Calculation in Treatments with [177Lu] Lu-DOTATATE. Correlation with Whole Body Absorbed Dose
    Monserrat Fuertes, T.
    Daci, L.
    Alvarez Amigo, A.
    Hierro Rivero, A.
    Garcia Balsa, A.
    Montenegro Iglesias, N.
    Blanco Rubio, J.
    Diaz Garcia, A.
    Menendez Garcia, C.
    Peinado Montes, M. A.
    Minguez Gabina, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S808 - S808
  • [33] Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
    Malcolm, Javian C.
    Falzone, Nadia
    Gains, Jennifer E.
    Aldridge, Matthew D.
    Mirando, David
    Lee, Boon Q.
    Gaze, Mark N.
    Vallis, Katherine A.
    EJNMMI PHYSICS, 2022, 9 (01)
  • [34] Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
    Javian C. Malcolm
    Nadia Falzone
    Jennifer E. Gains
    Matthew D. Aldridge
    David Mirando
    Boon Q. Lee
    Mark N. Gaze
    Katherine A. Vallis
    EJNMMI Physics, 9
  • [35] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Ha, Sejin
    Kim, Yong-il
    Oh, Jungsu S.
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    EJNMMI PHYSICS, 2024, 11 (01)
  • [36] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Sejin Ha
    Yong-il Kim
    Jungsu S. Oh
    Changhoon Yoo
    Baek-Yeol Ryoo
    Jin-Sook Ryu
    EJNMMI Physics, 11
  • [37] Towards cancer theranostics: 68Ga-, 44gSc-, 177Lu -, and 225Ac-labeled bombesin derivatives
    Ferguson, Simon
    Wuest, Melinda
    Bergman, Cody
    Thiele, Nikki
    Richter, Susan
    Jans, Hans-Sonke
    Radchenko, Valery
    Causey, Patrick
    Perron, Randy
    Schaffer, Paul
    Wilson, Justin
    Riauka, Terence
    Wuest, Frank
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S35 - S35
  • [38] Assessment of the radiation absorbed dose produced by 177Lu-iPSMA, 225Ac-iPSMA and 223RaCl2 to prostate cancer cell nuclei in a bone microenvironment model
    Azorin-Vega, Erika
    Rojas-Calderon, Eva
    Ferro-Flores, Guillermina
    Aranda-Lara, Liliana
    Jimenez-Mancilla, Nallely
    Nava-Cabrera, Miguel A.
    APPLIED RADIATION AND ISOTOPES, 2019, 146 : 66 - 71
  • [39] SatisfACtion: a phase 1/2 study of [225Ac]Ac-PSMA-R2 in patients with PSMA-positive metastatic castration-resistant prostate cancer with or without previous [177Lu]Lu-PSMA radioligand therapy
    Kraeber-Bodere, F.
    Mahammedi, H.
    Giraudet, A.
    Wehbe, J.
    Wilke, C.
    Olivier, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S280 - S280
  • [40] Clinical dosimetry in [177Lu]Lu-PSMA therapy: kidney mean absorbed dose difference between subsequent cycles
    Owers, E.
    Rijkhorst, E.
    Dotinga, M.
    de Wit-van der Veen, L. J.
    de Vries-Huizing, D. M. V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S368 - S368
12345